# MOLBASE (Shanghai) Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/molbase-shanghai-biotechnology-co

- Industry: Internet
- Headquarters: Shanghai, China
- Website: www.molbase.com
- Total disclosed funding: $10M
- Latest round: Series D (May 9, 2017)
- Investors on record: 7

## About

Founded in 2013 and based in Shanghai, China, MOLBASE (Shanghai) Biotechnology Co., Ltd operates as an e-commerce company that focuses on the operation and management of a chemical e-commerce platform. It was recognized as the National High-tech Enterprise. Dongliang Chang, the company's founder, has successively founded industrial companies such as Sinochem, Core Pharmaceuticals and Molbase. The company launched its commercial version website MOLBASE in September 2013.  In May 2017, MOLBASE (Shanghai) Biotechnology Co., Ltd closed a series D funding. In December 2019, the company was listed on the NASDAQ.

MOLBASE (Shanghai) Biotechnology Co., Ltd is mainly engaged in the operation and management of the chemical e-commerce platform. The platform provides online chemical data information, chemical catalogs, product supplier and buyer docking services, etc. Products include neuron product push system, mobile APP, spot mall, etc. Chemical products include 3M, Nippon Paint, and other brands.

The company generates revenue by providing a chemical e-commerce platform.

## Funding rounds

- Series D, May 9, 2017 — Hong Shan, Sinovation Ventures, Trustbridge Partners, Vangoo Capital Partners, TFTR Investment, Fosun RZ Capital
- Series C, Mar 17, 2016 — Hong Shan, Sinovation Ventures, Trustbridge Partners, Vangoo Capital Partners, Fosun RZ Capital
- Series B, Jun 16, 2015 — Kinzon Capital
- Series A, Dec 1, 2013, $10M — Sinovation Ventures, Trustbridge Partners

## Investors

- Sinovation Ventures (https://capitalatlas.ai/funds/sinovation-ventures) — Series A, Series C, Series D
- Trustbridge Partners (https://capitalatlas.ai/funds/trustbridge-partners) — Series A, Series C, Series D
- Kinzon Capital (https://capitalatlas.ai/funds/kinzon-capital) — Series B
- Hong Shan — Series C, Series D
- Vangoo Capital Partners (https://capitalatlas.ai/funds/vangoo-capital-partners) — Series C, Series D
- Fosun RZ Capital (https://capitalatlas.ai/funds/fosun-rz-capital) — Series C, Series D
- TFTR Investment (https://capitalatlas.ai/funds/tftr-investment) — Series D